AE Reports Prompt FDA, CDC to Hit Pause on Ixchiq Vaccine

The FDA and CDC recently issued a joint advisory statement recommending a pause in the use of the Ixchiq chikungunya vaccine in people 60 years of age and older, while they investigate reports of serious AEs